Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
US9295516B2 · kind B2 · utility
76Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2014 |
| Grant date | Mar 29, 2016 |
| Priority date | — |
| Expiry date | Jan 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2018/1425
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method for treating Chronic Obstructive Pulmonary Disease (COPD) or chronic bronchitis to alleviate the discomforts of breathing by using non-thermal electroporation energy to ablate diseased portions of the lung including the bronchus, airways and alveoli which, in effect, opens the restrictive diseased portions thereby maximizing the overall surface area thereof causing improved airflow and uninhibited breathing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.